rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Sopheon Terug naar discussie overzicht

Sopheon september 2021

15 Posts
| Omlaag ↓
  2. abc123xyz987 31 augustus 2021 20:00

    • abc123xyz987

      Lid sinds: 14 jul 2008

      Laatste bezoek: 24 dec 2024

    • Aanbevelingen

      Ontvangen: 42

      Gegeven: 2

    •    Aantal posts: 245

    The Company has been notified that Stuart Silcock, a non-executive director of the Company, has sold 74,328 ordinary shares of 20 pence each ("Shares") in the capital of the Company at a price of £9.63 per Share, pursuant to investor demand following the Company's recent results.



    Mr Silcock has also sold 5,000 Shares held in his dealing account as bare trustee for his grandchildren into his Self-Invested Personal Pension ("SIPP") and has sold 1,000 Shares from his SIPP to the Individual Savings Account ("ISA") of his spouse, Christine Silcock. Mrs Silcock has in turn sold 1,450 shares held in her dealing account to her ISA.



    Stuart Silcock's total beneficial interest in Ordinary Shares, including those held by his spouse or held on trust for family members, is now 279,490 Ordinary Shares.

    Groet ABC
  5. Gartje 10 september 2021 17:01

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    Heeft soof ook gezegd welk jaar ze iets terug doen voor hun aandeelhouders!!! Tik tik tik de tijd tikt door....
  6. marblesthegame 14 september 2021 08:13

    • marblesthegame

      Lid sinds: 06 jul 2005

      Laatste bezoek: 02 feb 2025

    • Aanbevelingen

      Ontvangen: 355

      Gegeven: 723

    •    Aantal posts: 1.442

    Sopheon PLC
    Issue of Equity

    RNS Number : 6232L
    Sopheon PLC
    13 September 2021

    For immediate release

    SOPHEON PLC
    ("Sopheon" or the "Company")


    Issue of Equity - Option Exercise


    Sopheon plc, the international provider of software, expertise and best practices for enterprise innovation management , announces that, following the exercise of options by an employee, it has allotted 11,715 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 17 September 2021.
  10. Gartje 20 september 2021 18:31

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    Maar eens is het vertrouwen weg, veel beloven maar weer ijzige stiltes en zakkende koersen. Kom op Soof doe eens wat voor je aandeelhouders!
  12. marblesthegame 24 september 2021 19:11

    • marblesthegame

      Lid sinds: 06 jul 2005

      Laatste bezoek: 02 feb 2025

    • Aanbevelingen

      Ontvangen: 355

      Gegeven: 723

    •    Aantal posts: 1.442

    Sopheon PLC
    Issue of Equity

    RNS Number : 9453M
    Sopheon PLC
    24 September 2021

    Issue of Equity - Option Exercise


    Sopheon plc, the international provider of software, expertise and best practices for enterprise innovation management , announces that, following the exercise of options by an employee, it has allotted 888 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 30 September 2021.

    The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,512,216. The Company does not hold any shares in treasury. Accordingly, the figure of 10,512,216 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
  15. Gartje 29 september 2021 16:40

    • Gartje

      Lid sinds: 26 aug 2016

      Laatste bezoek: 23 feb 2024

    • Aanbevelingen

      Ontvangen: 56

      Gegeven: 1

    •    Aantal posts: 955

    Kijk hier hebben we wat aan??, nu de koers nog een keer door die hatelijke 10 pond en ik ben dit jaar tevreden????
15 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 6.997
AB InBev 2 5.479
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.123
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.450
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.623
Aedifica 3 900
Aegon 3.258 322.602
AFC Ajax 537 7.084
Affimed NV 2 6.287
ageas 5.844 109.883
Agfa-Gevaert 14 2.046
Ahold 3.538 74.287
Air France - KLM 1.025 34.973
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.020
Alfen 16 24.234
Allfunds Group 4 1.468
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 403
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.806
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.834 242.589
AMG 971 133.002
AMS 3 73
Amsterdam Commodities 305 6.685
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 481
Antonov 22.632 153.605
Aperam 92 14.886
Apollo Alternative Assets 1 17
Apple 5 375
Arcadis 252 8.731
Arcelor Mittal 2.033 320.447
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.282
Aroundtown SA 1 219
Arrowhead Research 5 9.715
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.061
ASML 1.766 105.374
ASR Nederland 21 4.450
ATAI Life Sciences 1 7
Atenor Group 1 466
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.581
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.383